The extracranial occurrence of meningioma, which is a tumour of the central nervous system, is rare. Two cases of primary extracranial meningioma of the psammomatous variant are reported here. Both cases were managed successfully by endoscopic endonasal approach. Literature has been reviewed and their clinicopathological features are described.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460103 | PMC |
| http://dx.doi.org/10.1007/s12070-015-0856-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain Metastases.
J Clin Oncol
March 2025
Medical Oncology, Yale University School of Medicine, New Haven, CT.
Purpose: Anti-vascular endothelial growth factor therapy enhances PD-1 inhibitor activity in preclinical models and has been used to treat perilesional cerebral edema and radiation necrosis.
Methods: We conducted a two-institution phase II trial of bevacizumab and pembrolizumab in patients with untreated melanoma brain metastasis (MBM) (ClinicalTrials.gov identifier: NCT02681549).
Safety of intravenous thrombolysis in central retinal artery occlusion patients with concomitant acute cerebral infarctions.
J Neurol Sci
April 2025
Departments of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. Electronic address:
Background And Objectives: Central retinal artery occlusion (CRAO) results in severe visual impairment. Intravenous thrombolysis (IVT) is a potential treatment for CRAO, but ambiguous data regarding efficacy and the possibility that the presence of cerebral infarctions may increase the risk of symptomatic intracranial hemorrhage (sICH) raise concerns. The aim of the current study was to evaluate the safety of IVT in patients with CRAO.
View Article and Find Full Text PDFNational Trends in Radiation Treatment for Small Cell Lung Cancer Brain Metastases in the Modern Era.
Adv Radiat Oncol
March 2025
Department of Radiation Oncology, Allegheny Health Network Cancer Institute, Pittsburgh, Pennsylvania.
Purpose: Small cell lung cancer (SCLC) is a highly aggressive form of lung cancer that often leads to brain metastases. Traditional treatment has largely relied on whole brain radiation therapy (WBRT). However, concerns about neurocognitive side effects have led to the adoption of advanced techniques such as hippocampal avoidance WBRT (HA-WBRT) and stereotactic radiosurgery (SRS).
View Article and Find Full Text PDFExternal Validation of an Extended Prognostic Assessment Model in Patients With Brain Metastases from Small-cell Lung Cancer.
Cancer Diagn Progn
March 2025
Department of Radiation Oncology, University Hospital Freiburg, Freiburg, Germany.
Background/aim: Recently, the small-cell lung cancer (SCLC) grade model for patients with brain metastases was developed by a Japanese group. It includes sex, performance status, number of brain metastases, primary tumor control and presence of extracranial metastases. The aim of the present study was to validate this prognostic score in a European cohort of patients.
View Article and Find Full Text PDFHigh-Grade Glioma With Parotid Metastasis: A Case Report of Long-Term Treatment and Follow-Up.
Cureus
January 2025
Neurosurgery, Hamad General Hospital, Doha, QAT.
High-grade gliomas (WHO Grade 4) are aggressive and common primary brain tumors of glial origin with poor prognosis. The classification of high-grade astrocytomas has evolved, improving the distinction between tumor subtypes. Previously, isocitrate dehydrogenase (IDH)-mutant astrocytomas that progressed to Grade 4 were referred to as secondary glioblastomas.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!